Inactief instrument

Agenda Alexion Pharmaceuticals, Inc.

Aandelen

ALXN

US0153511094

Grafiek agenda Alexion Pharmaceuticals, Inc.

3e79c27e21dc817be.UKBzY69sv5314JQTwomH7q4Pch9Y6TLD5w_flje7M-U.CpFEVOcc7dC8sKJl78K2hOhoCikeu3mq1V3u8V_dfqgTzwsiliXq97rR9w~f7404d80a42fc669cade7093a9365656

Komende gebeurtenissen op Alexion Pharmaceuticals, Inc.

Geen evenementen beschikbaar

Gebeurtenissen op naam

27-04-2023 21:42 American Academy of Neurology Meeting - Oral Presentation No S50.002
27-04-2023 14:00 American Academy of Neurology Meeting - Poster No P13.5-011
26-04-2023 17:45 American Academy of Neurology Meeting - Poster No P11.4-005
25-04-2023 23:30 American Academy of Neurology Meeting - Poster No P9.5-032
25-04-2023 14:00 American Academy of Neurology Meeting - Poster No P7.8-007
24-04-2023 22:42 American Academy of Neurology Meeting - Oral Presentation No S19.007
23-04-2023 20:36 American Academy of Neurology Meeting - Oral Presentation No Oral Presentation
23-04-2023 20:24 American Academy of Neurology Meeting - Oral Presentation No S5.008
23-04-2023 19:36 American Academy of Neurology Meeting - Oral Presentation No S5.004
23-04-2023 19:24 American Academy of Neurology Meeting - Oral Presentation No S5.003
23-04-2023 19:12 American Academy of Neurology Meeting - Oral Presentation No S5.002
23-04-2023 14:00 American Academy of Neurology Meeting - Poster No P1.5-016
23-04-2023 14:00 American Academy of Neurology Meeting - Poster No P1.5-003
23-04-2023 14:00 American Academy of Neurology Meeting - Poster No P1.5-008
23-04-2023 14:00 American Academy of Neurology Meeting - Poster No P1.5-002
23-04-2023 14:00 American Academy of Neurology Meeting - Poster No P1.5-020
23-04-2023 14:00 American Academy of Neurology Meeting - Poster No P1.5-004
23-04-2023 14:00 American Academy of Neurology Meeting - Poster No P1.5-013
09-06-2021 European Hematology Association Congress - Abstract Number : EP1017
09-06-2021 European Hematology Association Congress - Abstract Number : EP1018
  1. Beurs
  2. Aandelen
  3. Koers ALXN
  4. Agenda Alexion Pharmaceuticals, Inc.